Cold Plasma Market Outlook:
Cold Plasma Market size was valued at USD 2.44 billion in 2025 and is likely to cross USD 8.66 billion by 2035, expanding at more than 13.5% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of cold plasma is assessed at USD 2.74 billion.
The growth of the market can be attributed to surge in people affected by chronic wounds. The prevalence of chronic wounds is high among people suffering from various chronic disease. Therefore, with the growing prevalence of chronic disease, the risk of chronic wound increases. In 2022, the global prevalence of chronic wounds was forecast to be 1.51 to 2.21 per 1000 people. However, the frequency is anticipated to increase as populations around the world get older. Therefore, the demand for cold plasma is estimated to increase, since it has proved to be effective in healing wounds.
Moreover, the prevalence of spread of infection in hospitals is also high. Hospital acquired infections (HAIs) are important issues that require urgent attention on a global scale. HAIs are a class of infections that a patient did not have prior to being admitted to the hospital. HAIs don't even exist during the latency period; instead, they appear within few hours of a patient admitting the hospital. The fifth most frequent type of illness related with healthcare is urinary tract infections (UTIs). At some point during their hospital stay, 12%–16% of adult inpatients would have an indwelling urinary catheter (IUC). For every day the IUC is present, a patient's chance of developing a catheter-associated urinary tract infection increases by 3%–7%. Hence, for the purpose of eliminating all varieties of harmful microorganisms, cold plasma may serve as a valuable tool.
